Gilead Sciences, Inc.

Get the info you need on these new drug indications, part of our drug news roundup for September.

A review of new launches, new indications, new dosage forms and Health Canada advisories.

Our clinical writer Lu-Ann Murdoch keeps up to date on all the latest drug news in Canada. This summer she's highlighted many new indications for existing drugs including Zeposia, Jardiance and Gardasil 9.

Intended for outpatients with a positive SARS-CoV-2 test result who are at high risk for progression to severe COVID-19.

Merck’s molnupiravir is a twice-daily oral antiviral agent currently under study as a potential treatment for mild/moderate COVID-19.

WHO finds insufficient evidence that remdesivir improves survival or other outcomes in hospitalized patients with COVID-19, regardless of disease severity.

There will be a dramatic resurgence of COVID-19 cases in Canada unless people limit contact with others in coming days, the country's chief public health officer warns. "We don't want it to go up a giant ski hill,'' Dr. Theresa Tam said Tuesday as she described the potential for a sharp upward curve.

One U.S. study found recovery in patients using the drug was shortened by 31%—11 days on average versus 15 days for those just given usual care